Cargando…
Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues
Autophagy is thought to be involved in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, how SARS-CoV-2 interferes with the autophagic pathway and whether autophagy contributes to virus infection in vivo is unclear. In this study, we identified SARS-CoV-2-triggered aut...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610582/ https://www.ncbi.nlm.nih.gov/pubmed/34550769 http://dx.doi.org/10.1128/JVI.01537-21 |
_version_ | 1784603125758296064 |
---|---|
author | Shang, Chao Zhuang, Xinyu Zhang, He Li, Yiquan Zhu, Yilong Lu, Jing Ge, Chenchen Cong, Jianan Li, Tingyu Li, Nan Tian, Mingyao Jin, Ningyi Li, Xiao |
author_facet | Shang, Chao Zhuang, Xinyu Zhang, He Li, Yiquan Zhu, Yilong Lu, Jing Ge, Chenchen Cong, Jianan Li, Tingyu Li, Nan Tian, Mingyao Jin, Ningyi Li, Xiao |
author_sort | Shang, Chao |
collection | PubMed |
description | Autophagy is thought to be involved in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, how SARS-CoV-2 interferes with the autophagic pathway and whether autophagy contributes to virus infection in vivo is unclear. In this study, we identified SARS-CoV-2-triggered autophagy in animal models, including the long-tailed or crab-eating macaque (Macaca fascicularis), human angiotensin-converting enzyme 2 (hACE2) transgenic mice, and xenografted human lung tissues. In Vero E6 and Huh-7 cells, SARS-CoV-2 induces autophagosome formation, accompanied by consistent autophagic events, including inhibition of the Akt-mTOR pathway and activation of the ULK-1-Atg13 and VPS34-VPS15-Beclin1 complexes, but it blocks autophagosome-lysosome fusion. Modulation of autophagic elements, including the VPS34 complex and Atg14, but not Atg5, inhibits SARS-CoV-2 replication. Moreover, this study represents the first to demonstrate that the mouse bearing xenografted human lung tissue is a suitable model for SARS-CoV-2 infection and that autophagy inhibition suppresses SARS-CoV-2 replication and ameliorates virus-associated pneumonia in human lung tissues. We also observed a critical role of autophagy in SARS-CoV-2 infection in an hACE2 transgenic mouse model. This study, therefore, gives insights into the mechanisms by which SARS-CoV-2 manipulates autophagosome formation, and we suggest that autophagy-inhibiting agents might be useful as therapeutic agents against SARS-CoV-2 infection. IMPORTANCE Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic with limited therapeutics. Insights into the virus-host interactions contribute substantially to the development of anti-SARS-CoV-2 therapeutics. The novelty of this study is the use of a new animal model: mice xenografted with human lung tissues. Using a combination of in vitro and in vivo studies, we have obtained experimental evidence that induction of autophagy contributes to SARS-CoV-2 infection and improves our understanding of potential therapeutic targets for SARS-CoV-2. |
format | Online Article Text |
id | pubmed-8610582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-86105822021-12-07 Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues Shang, Chao Zhuang, Xinyu Zhang, He Li, Yiquan Zhu, Yilong Lu, Jing Ge, Chenchen Cong, Jianan Li, Tingyu Li, Nan Tian, Mingyao Jin, Ningyi Li, Xiao J Virol Virus-Cell Interactions Autophagy is thought to be involved in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, how SARS-CoV-2 interferes with the autophagic pathway and whether autophagy contributes to virus infection in vivo is unclear. In this study, we identified SARS-CoV-2-triggered autophagy in animal models, including the long-tailed or crab-eating macaque (Macaca fascicularis), human angiotensin-converting enzyme 2 (hACE2) transgenic mice, and xenografted human lung tissues. In Vero E6 and Huh-7 cells, SARS-CoV-2 induces autophagosome formation, accompanied by consistent autophagic events, including inhibition of the Akt-mTOR pathway and activation of the ULK-1-Atg13 and VPS34-VPS15-Beclin1 complexes, but it blocks autophagosome-lysosome fusion. Modulation of autophagic elements, including the VPS34 complex and Atg14, but not Atg5, inhibits SARS-CoV-2 replication. Moreover, this study represents the first to demonstrate that the mouse bearing xenografted human lung tissue is a suitable model for SARS-CoV-2 infection and that autophagy inhibition suppresses SARS-CoV-2 replication and ameliorates virus-associated pneumonia in human lung tissues. We also observed a critical role of autophagy in SARS-CoV-2 infection in an hACE2 transgenic mouse model. This study, therefore, gives insights into the mechanisms by which SARS-CoV-2 manipulates autophagosome formation, and we suggest that autophagy-inhibiting agents might be useful as therapeutic agents against SARS-CoV-2 infection. IMPORTANCE Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic with limited therapeutics. Insights into the virus-host interactions contribute substantially to the development of anti-SARS-CoV-2 therapeutics. The novelty of this study is the use of a new animal model: mice xenografted with human lung tissues. Using a combination of in vitro and in vivo studies, we have obtained experimental evidence that induction of autophagy contributes to SARS-CoV-2 infection and improves our understanding of potential therapeutic targets for SARS-CoV-2. American Society for Microbiology 2021-11-23 /pmc/articles/PMC8610582/ /pubmed/34550769 http://dx.doi.org/10.1128/JVI.01537-21 Text en Copyright © 2021 American Society for Microbiology. https://doi.org/10.1128/ASMCopyrightv2All Rights Reserved (https://doi.org/10.1128/ASMCopyrightv2) . https://doi.org/10.1128/ASMCopyrightv2This article is made available via the PMC Open Access Subset for unrestricted noncommercial re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Virus-Cell Interactions Shang, Chao Zhuang, Xinyu Zhang, He Li, Yiquan Zhu, Yilong Lu, Jing Ge, Chenchen Cong, Jianan Li, Tingyu Li, Nan Tian, Mingyao Jin, Ningyi Li, Xiao Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues |
title | Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues |
title_full | Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues |
title_fullStr | Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues |
title_full_unstemmed | Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues |
title_short | Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues |
title_sort | inhibition of autophagy suppresses sars-cov-2 replication and ameliorates pneumonia in hace2 transgenic mice and xenografted human lung tissues |
topic | Virus-Cell Interactions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610582/ https://www.ncbi.nlm.nih.gov/pubmed/34550769 http://dx.doi.org/10.1128/JVI.01537-21 |
work_keys_str_mv | AT shangchao inhibitionofautophagysuppressessarscov2replicationandamelioratespneumoniainhace2transgenicmiceandxenograftedhumanlungtissues AT zhuangxinyu inhibitionofautophagysuppressessarscov2replicationandamelioratespneumoniainhace2transgenicmiceandxenograftedhumanlungtissues AT zhanghe inhibitionofautophagysuppressessarscov2replicationandamelioratespneumoniainhace2transgenicmiceandxenograftedhumanlungtissues AT liyiquan inhibitionofautophagysuppressessarscov2replicationandamelioratespneumoniainhace2transgenicmiceandxenograftedhumanlungtissues AT zhuyilong inhibitionofautophagysuppressessarscov2replicationandamelioratespneumoniainhace2transgenicmiceandxenograftedhumanlungtissues AT lujing inhibitionofautophagysuppressessarscov2replicationandamelioratespneumoniainhace2transgenicmiceandxenograftedhumanlungtissues AT gechenchen inhibitionofautophagysuppressessarscov2replicationandamelioratespneumoniainhace2transgenicmiceandxenograftedhumanlungtissues AT congjianan inhibitionofautophagysuppressessarscov2replicationandamelioratespneumoniainhace2transgenicmiceandxenograftedhumanlungtissues AT litingyu inhibitionofautophagysuppressessarscov2replicationandamelioratespneumoniainhace2transgenicmiceandxenograftedhumanlungtissues AT linan inhibitionofautophagysuppressessarscov2replicationandamelioratespneumoniainhace2transgenicmiceandxenograftedhumanlungtissues AT tianmingyao inhibitionofautophagysuppressessarscov2replicationandamelioratespneumoniainhace2transgenicmiceandxenograftedhumanlungtissues AT jinningyi inhibitionofautophagysuppressessarscov2replicationandamelioratespneumoniainhace2transgenicmiceandxenograftedhumanlungtissues AT lixiao inhibitionofautophagysuppressessarscov2replicationandamelioratespneumoniainhace2transgenicmiceandxenograftedhumanlungtissues |